Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income	$ 30,631	$ 40,910
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,218	3,931
Net amortization of premiums on securities	2,736	2,452
Provision (Benefit) for credit losses	2,882	(6,603)
Share-based compensation	1,390	778
Deferred income tax expense	(646)	2,333
Proceeds from sale of loans held for sale	18,768	42,767
Originations of loans held for sale	(16,094)	(40,523)
Income on company owned life insurance	(1,702)	(1,350)
Net gain on sale of loans held for sale	(737)	(1,868)
Net (loss) gain on investment securities	15	(71)
Net gain on other assets	(7)	(148)
Noncash restructuring charges against assets	1,269	11
(Increase) decrease in other assets	(14,393)	2,950
Increase (decrease) in other liabilities	53,454	(14,620)
Net cash provided by operating activities	81,784	30,949
Cash flows from investing activities:
Purchases of available for sale securities	(75,269)	(411,641)
Purchases of held to maturity securities	(36,035)	(1,830)
Proceeds from principal payments, maturities and calls on available for sale securities	68,269	70,596
Proceeds from principal payments, maturities and calls on held to maturity securities	36,265	54,288
Proceeds from sales of securities available for sale	6,252	51,891
Net loan originations	(84,329)	(37,523)
Purchases of company owned life insurance, net of proceeds received	(10,011)	(12)
Proceeds from sales of other assets	0	2,459
Purchases of premises and equipment	(3,999)	(6,284)
Cash consideration paid for acquisition, net of cash acquired	0	(759)
Net cash used in investing activities	(98,857)	(278,815)
Cash flows from financing activities:
Net (decrease) increase in deposits	(6,574)	380,854
Net increase (decrease) in short-term borrowings	79,000	(5,300)
Repurchase of preferred stock	0	(43)
Purchases of common stock for treasury	(15,327)	(5,964)
Cash dividends paid to common and preferred shareholders	(9,433)	(9,172)
Net cash provided by financing activities	47,666	360,375
Net increase in cash and cash equivalents	30,593	112,509
Cash and cash equivalents, beginning of period	79,112	93,878
Cash and cash equivalents, end of period	$ 109,705	$ 206,387